{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:43:54Z","timestamp":1790232234143,"version":"4.1.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"crossref","award":["2016\/21\/D\/NZ7\/01548"],"award-info":[{"award-number":["2016\/21\/D\/NZ7\/01548"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"crossref","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11095-017-2199-y","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T11:33:40Z","timestamp":1496748820000},"page":"2614-2627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":226,"title":["Metformin \u2013 a Future Therapy for Neurodegenerative Diseases"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-6550","authenticated-orcid":false,"given":"Magdalena","family":"Markowicz-Piasecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szyd\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Skupie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Mikiciuk-Olasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/S0149-2918(03)90089-0","volume":"25","author":"SM Setter","year":"2003","unstructured":"Setter SM, Iltz JL, Thams J, Campbell RK. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clin Ther. 2003;25:2991\u20133026.","journal-title":"Clin Ther"},{"key":"2199_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mad.2015.08.001","volume":"150","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Fang P, Shia M, Zhu Y, Bo P. Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer\u2019s disease. Mech Ageing dev. 2015;150:20\u20136.","journal-title":"Mech Ageing dev"},{"issue":"6","key":"2199_CR3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.clinthera.2015.01.002","volume":"37","author":"H Ascher-Svanum","year":"2015","unstructured":"Ascher-Svanum H, Chen YF, Hake A, Kahle-Wrobleski K, Schuster D, Kendall D, et al. Cognitive and functional decline in patients with mild Alzheimer dementia with or without comorbid diabetes. Clin Ther. 2015;37(6):1195\u2013205.","journal-title":"Clin Ther"},{"issue":"1","key":"2199_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharm Ther. 2012;136(1):82\u201393.","journal-title":"Pharm Ther"},{"key":"2199_CR5","doi-asserted-by":"crossref","unstructured":"Li J, Cesari M, Liu F, Dong B, Vellas B. Effects of diabetes mellitus on cognitive decline in patients with Alzheimer disease: a systematic review. Can J Diabetes. 2016:1\u20136.","DOI":"10.1016\/j.jcjd.2016.07.003"},{"issue":"3","key":"2199_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","volume":"2","author":"C Patrone","year":"2014","unstructured":"Patrone C, Eriksson O, Lindholm D. Diabetes drugs and neurological disorders: new views and therapeutic possibilities. Lancet Diabetes Endocrinol. 2014;2(3):256\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2199_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4172\/2155-6156.1000107e","volume":"2","author":"YK Bashmakov","year":"2011","unstructured":"Bashmakov YK, Petyaev IM. Old drug acquires new target: metformin and Sirt1. J Diabetes Metab. 2011;2:107.","journal-title":"J Diabetes Metab"},{"key":"2199_CR8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2013.02.038","volume":"705","author":"CV Rizos","year":"2013","unstructured":"Rizos CV, Elisaf MS. Metformin and cancer. Eur J Pharm. 2013;705:96\u2013108.","journal-title":"Eur J Pharm"},{"key":"2199_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612822666161201152941","volume":"23","author":"M Markowicz-Piasecka","year":"2017","unstructured":"Markowicz-Piasecka M, Huttunen KM, Mateusiak \u0141, Mikiciuk-Olasik E, Sikora J. Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics. Curr Pharm Design. 2017;23:1\u201319.","journal-title":"Curr Pharm Design"},{"key":"2199_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2008.03.009","volume":"57","author":"G Mazzaglia","year":"2008","unstructured":"Mazzaglia G, Yurgin N, Boye KS, Trifiro G, Cottrell S, Allene E, et al. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. Pharm res. 2008;57:358\u201363.","journal-title":"Pharm res"},{"key":"2199_CR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diabres.2011.05.004","volume":"93","author":"M Baviera","year":"2011","unstructured":"Baviera M, Monesi L, Marzona I, Avanzini F, Monesi G. Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy\u2019s Lombardy region: a large population-based study. Diabetes res Clin PR. 2011;93:123\u201330.","journal-title":"Diabetes res Clin PR"},{"issue":"1","key":"2199_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2012.10.011","volume":"24","author":"K Mahmood","year":"2013","unstructured":"Mahmood K, Naeem M, Rahimnajjad NA. Metformin: the hidden chronicles of a magic drug. Eur J Int med. 2013;24(1):20\u20136.","journal-title":"Eur J Int med"},{"key":"2199_CR13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2016.05.148","volume":"477","author":"C Wang","year":"2016","unstructured":"Wang C, Liu C, Gao K, Zhao H, Zhou Z, Shen Z, et al. Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury. Biochem Biophys res com. 2016;477:534\u201340.","journal-title":"Biochem Biophys res com"},{"key":"2199_CR14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","volume":"26","author":"K Isoda","year":"2006","unstructured":"Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol. 2006;26:611\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2199_CR15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","volume":"63","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 2004;63:1187\u201392.","journal-title":"Neurology"},{"key":"2199_CR16","unstructured":"http:\/\/clinicaltrials.gov . [Accessed February 12, 2017]."},{"key":"2199_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/rej.2011.1238","volume":"14","author":"AR Mendelsohn","year":"2011","unstructured":"Mendelsohn AR, Larrick JW. Rapamycin as an antiaging therapeutic? Targeting mammalian target of rapamycin to treat Hutchinson\u2013Gilford progeria and neurodegenerative diseases. Rejuvenation res. 2011;14:437\u201341.","journal-title":"Rejuvenation res"},{"key":"2199_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainresbull.2016.02.005","volume":"121","author":"M Asadbegia","year":"2016","unstructured":"Asadbegia M, Yaghmaeia P, Salehib I, Ebrahim-Habibic A, Komaki A. Neuroprotective effects of metformin against A\u03b2-mediated inhibition of long-term potentiation in rats fed a high-fat diet. Brain res Bull. 2016;121:178\u201385.","journal-title":"Brain res Bull"},{"key":"2199_CR19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","volume":"60","author":"A Gupta","year":"2011","unstructured":"Gupta A, Bisht B, Dey CS. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes. Neuropharmacology. 2011;60:910\u201320.","journal-title":"Neuropharmacology"},{"key":"2199_CR20","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1073\/pnas.0807991106","volume":"106","author":"Y Chen","year":"2009","unstructured":"Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma T, et al. Antidiabetic drug metformin (GlucophageR) increasesbiogenesis of Alzheimer\u2019s amyloid peptides via up-regulating BACE1transcription. Proc Natl Acad Sci U S a. 2009;106:3907\u201312.","journal-title":"Proc Natl Acad Sci U S a"},{"key":"2199_CR21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","volume":"60","author":"P Imfeld","year":"2012","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR. Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019sdisease: a population-based case-control study. J am Geriatr Soc. 2012;60:916\u201321.","journal-title":"J am Geriatr Soc"},{"key":"2199_CR22","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","volume":"117","author":"GV Johnson","year":"2004","unstructured":"Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci. 2004;117:5721\u20139.","journal-title":"J Cell Sci"},{"issue":"Suppl. 1","key":"2199_CR23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1471-4159.2011.07515.x","volume":"120","author":"X Sun","year":"2012","unstructured":"Sun X, Bromley-Brits K, Song W. Regulation of beta-site APPcleaving enzyme 1 gene expression and its role in Alzheimer\u2019s disease. J Neurochem. 2012;120(Suppl. 1):62\u201370.","journal-title":"J Neurochem"},{"key":"2199_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","volume":"250","author":"Y Yang","year":"2013","unstructured":"Yang Y, Song W. Molecular links between Alzheimer\u2019s disease and diabetes mellitus. Neuroscience. 2013;250:140\u201350.","journal-title":"Neuroscience"},{"key":"2199_CR25","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","volume":"24","author":"S Monte dela","year":"2014","unstructured":"dela Monte S. Type 3 diabetes is sporadic Alzheimer's disease: Mini-review. Eur. Neuropsychopharm. 2014;24:1954\u201360.","journal-title":"Eur. Neuropsychopharm"},{"key":"2199_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64\u201374.","journal-title":"Lancet Neurol"},{"key":"2199_CR27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","volume":"16","author":"D Kopf","year":"2009","unstructured":"Kopf D, Frolich L. Risk of incident Alzheimer\u2019s disease in diabetic patients: a systematic review of prospective trials. J Alzheimers dis. 2009;16:677\u201385.","journal-title":"J Alzheimers dis"},{"issue":"4","key":"2199_CR28","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes. 2002;51(4):1256\u201362.","journal-title":"Diabetes"},{"issue":"5","key":"2199_CR29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61(5):661\u20136.","journal-title":"Arch Neurol"},{"key":"2199_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","volume":"124","author":"J Zhang","year":"2017","unstructured":"Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease. Diabetes res Clin Pract. 2017;124:41\u20137.","journal-title":"Diabetes res Clin Pract"},{"key":"2199_CR31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","volume":"12","author":"EL Abnera","year":"2016","unstructured":"Abnera EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, et al. Diabetes is associated with cerebrovascular but not Alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2016;12:882\u20139.","journal-title":"Alzheimers Dement"},{"key":"2199_CR32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","volume":"60","author":"MS Beeri","year":"2005","unstructured":"Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J. Type 2 diabetes is negatively associated with Alzheimer\u2019s disease neuropathology. J Gerontol a Biol Sci med Sci. 2005;60:471\u20135.","journal-title":"J Gerontol a Biol Sci med Sci"},{"key":"2199_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archneurol.2008.579","volume":"66","author":"JA Sonnen","year":"2009","unstructured":"Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009;66:315\u201322.","journal-title":"Arch Neurol"},{"key":"2199_CR34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"2199_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu rev med. 1996;47:387\u2013400.","journal-title":"Annu rev med"},{"key":"2199_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z","volume":"48","author":"GE Gibson","year":"2000","unstructured":"Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, et al. Mitochondrial damage in Alzheimer\u2019s disease varies with apolipoprotein E genotype. Ann Neurol. 2000;48:297\u2013303.","journal-title":"Ann Neurol"},{"key":"2199_CR37","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.2337\/db14-0122","volume":"63","author":"M Brundel","year":"2014","unstructured":"Brundel M, Reijmer YD, van Veluw SJ, Kujif HJ, Luijten PR, Kappelle LJ. Cerebral microvascular lesions on high-resolution 7-TeslaMRI in patients with type 2 diabetes. Diabetes. 2014;63:3523\u20139.","journal-title":"Diabetes"},{"key":"2199_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"1","author":"H Lashen","year":"2010","unstructured":"Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;1:117\u201328.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2199_CR39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854\u201365.","journal-title":"Lancet"},{"issue":"2","key":"2199_CR40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.016","volume":"25","author":"Y Mima","year":"2016","unstructured":"Mima Y, Kuwashiro T, Yasaka M, Tsurusaki Y, Nakamura A, Wakugawa Y, et al. Impact of metformin on the severity and outcomes of acute ischemic stroke in patients with type 2 diabetes mellitus. J Stroke Cerebrovasc dis. 2016;25(2):436\u201346.","journal-title":"J Stroke Cerebrovasc dis"},{"key":"2199_CR41","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/S1262-3636(03)72785-2","volume":"29","author":"R Giannarelli","year":"2003","unstructured":"Giannarelli R, Aragona M, Cappelli A. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 2003;29:6528\u201335.","journal-title":"Diabetes Metab"},{"issue":"7","key":"2199_CR42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1517\/14728222.2015.1025051","volume":"19","author":"R Ladeiras-Lopes","year":"2015","unstructured":"Ladeiras-Lopes R, Fontes-Carvalho R, Bettencourt N, Sampaio F, Gama V, Leite-Moreira A. A novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease. Expert Opin Ther Targets. 2015;19(7):869\u201377.","journal-title":"Expert Opin Ther Targets"},{"key":"2199_CR43","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1447-0756.2011.01839.x","volume":"38","author":"L Dong","year":"2012","unstructured":"Dong L, Zhou Q, Zhang Z, Zhu Y, Duan T, Feng Y. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expres- sion. J Obstet Gynaecol res. 2012;38:1077\u201385.","journal-title":"J Obstet Gynaecol res"},{"key":"2199_CR44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2012.01.009","volume":"125","author":"RK Hanna","year":"2012","unstructured":"Hanna RK, Zhou C, Malloy KM, Sun L, Zhong Y, Gehrig PA, et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol Oncol. 2012;125:458\u201369.","journal-title":"Gynecol Oncol"},{"key":"2199_CR45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","volume":"34","author":"AE Riedmaier","year":"2013","unstructured":"Riedmaier AE, Fisel P, Nies AT, Schaeffeler E, Schwab M. Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects. Trends Pharm Sci. 2013;34:126\u201335.","journal-title":"Trends Pharm Sci"},{"key":"2199_CR46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81\u201398.","journal-title":"Clin Pharmacokinet"},{"key":"2199_CR47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpba.2009.04.033","volume":"50","author":"KM Huttunen","year":"2009","unstructured":"Huttunen KM, Rautio J, Lepp\u00e4nena J, Veps\u00e4l\u00e4inen J, Keski-Rahkonen P. Determination of metformin and its prodrugs in human and rat blood by hydrophilic interaction liquid chromatography. J Pharm Biomed Anal. 2009;50:469\u201374.","journal-title":"J Pharm Biomed Anal"},{"key":"2199_CR48","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm493244.htm . Access 5.01.2016."},{"key":"2199_CR49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2014.04.130","volume":"448","author":"RR Zhao","year":"2014","unstructured":"Zhao RR, Xu XC, Xu F, Zhang WL, Zhang WL, Liu LM, et al. Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice. Biochem Biophys res Commun. 2014;448:414\u20137.","journal-title":"Biochem Biophys res Commun"},{"key":"2199_CR50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1570159X11666131120223201","volume":"12","author":"KH Alzoubi","year":"2014","unstructured":"Alzoubi KH, Khabour OF, Al-Azzam SI, Tashtoush MH, Mhaidat NM. Metformin eased cognitive impairment induced by chronic L-methionine administration: potential role of oxidative stress. Curr Neuropharmacol. 2014;12:186\u201392.","journal-title":"Curr Neuropharmacol"},{"key":"2199_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2015.12.012","volume":"301","author":"JS Allard","year":"2015","unstructured":"Allard JS, Perez EJ, Fukui K, Carpenter P, Ingram DK, Cabo R. Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL\/6J mice. Behav Brain res. 2015;301:1\u20139.","journal-title":"Behav Brain res"},{"issue":"5","key":"2199_CR52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5455\/njppp.2015.5.1208201564","volume":"5","author":"Z Ashrostaghi","year":"2015","unstructured":"Ashrostaghi Z, Ganji F, Sepehri H. Effect of metformin on the spatial memory in aged rats. Nat J Phys Pharm Pharmacol. 2015;5(5):416\u201321.","journal-title":"Nat J Phys Pharm Pharmacol"},{"key":"2199_CR53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","volume":"101","author":"F Chen","year":"2016","unstructured":"Chen F, Dong RR, Zhong KL, Ghosh A, Tang SS, Long Y, et al. Antidiabetic drugs restore abnormal transport of amyloid-beta across the blood-brain barrier and memory impairment in db\/db mice. Neuropharmacology. 2016;101:123\u201336.","journal-title":"Neuropharmacology"},{"key":"2199_CR54","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s00125-012-2686-y","volume":"55","author":"AD McNeilly","year":"2012","unstructured":"McNeilly AD, Williamson R, Balfour DJK, Stewart CA, Sutherland C. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia. 2012;55:3061\u201370.","journal-title":"Diabetologia"},{"key":"2199_CR55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2014.06.026","volume":"86","author":"R Lennox","year":"2014","unstructured":"Lennox R, Porter DW, Flatt PR, Holscher C, Irwin N, Gault VA. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice. Neuropharmacology. 2014;86:22\u201330.","journal-title":"Neuropharmacology"},{"issue":"3","key":"2199_CR56","volume":"11","author":"W Zhou","year":"2016","unstructured":"Zhou W, Kavelaars A, Heijnen CJ. Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One. 2016;11(3):e0151890.","journal-title":"PLoS One"},{"key":"2199_CR57","first-page":"61","volume":"41","author":"TP Ng","year":"2016","unstructured":"Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B. Long-term metformin usage and cognitive function among older adults with diabetes. J Alzheimer\u2019s Disease. 2016;41:61\u20138.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2199_CR58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","volume":"41","author":"M Guo","year":"2014","unstructured":"Guo M, Mi Y, Jiang QM, Xu JM, Tang YY, Tian G, et al. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharm Phys. 2014;41:650\u20136.","journal-title":"Clin Exp Pharm Phys"},{"key":"2199_CR59","unstructured":"Herath PM, Cherbuin N, Eramudugolla R, Anstey KJ. The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study. BioMed Res. Int. 2016; Article ID 7208429, doi.org\/10.1155\/2016\/7208429 ."},{"key":"2199_CR60","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","volume":"36","author":"EM Moore","year":"2013","unstructured":"Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 2013;36:2981\u20137.","journal-title":"Diabetes Care"},{"key":"2199_CR61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/0253-7176.185952","volume":"38","author":"D Khattar","year":"2016","unstructured":"Khattar D, Khaliq F, Vaney N, Madhu SV. Is metformin-induced vitamin B12 deficiency responsible for cognitive decline in type 2 diabetes? Indian J Psychol med. 2016;38:285\u201390.","journal-title":"Indian J Psychol med"},{"key":"2199_CR62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu rev Biochem. 2006;75:333\u201366.","journal-title":"Annu rev Biochem"},{"key":"2199_CR63","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat med. 2008;14:837\u201342.","journal-title":"Nat med"},{"key":"2199_CR64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","volume":"572","author":"M Townsend","year":"2006","unstructured":"Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol. 2006;572:477\u201392.","journal-title":"J Physiol"},{"key":"2199_CR65","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes res. 1988;9:151\u20139.","journal-title":"Diabetes res"},{"key":"2199_CR66","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","volume":"46","author":"S Luca","year":"2007","unstructured":"Luca S, Yau WM, Leapman R, Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry. 2007;46:13505\u201322.","journal-title":"Biochemistry"},{"key":"2199_CR67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","volume":"250","author":"S Gebre-Medhin","year":"1998","unstructured":"Gebre-Medhin S, Mulder H, Pekny M, Westermark G, Tornell J, Westermark P, et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys res Commun. 1998;250:271\u20137.","journal-title":"Biochem Biophys res Commun"},{"key":"2199_CR68","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","volume":"273","author":"B Konarkowska","year":"2006","unstructured":"Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS j. 2006;273:3614\u201324.","journal-title":"FEBS j"},{"key":"2199_CR69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","volume":"347","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Cheng YC, Chen SJ, Yen CH, Huang RN. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cell agains amyloid-beta-induced mitochodrial dysfunction. Exp Cell res. 2016;347:322\u201331.","journal-title":"Exp Cell res"},{"key":"2199_CR70","first-page":"720","volume":"2015","author":"MM Chung","year":"1852","unstructured":"Chung MM, Chen YL, Pei D, Cheng YC, Sun B, Nicol CJ, et al. The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent. Bioch Bioph Acta. 1852;2015:720\u201331.","journal-title":"Bioch Bioph Acta"},{"issue":"3","key":"2199_CR71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","volume":"5","author":"JH Scarpello","year":"2008","unstructured":"Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc dis res. 2008;5(3):157\u201367.","journal-title":"Diab Vasc dis res"},{"issue":"9","key":"2199_CR72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.nrl.2013.05.006","volume":"29","author":"RO Dom\u00ednguez","year":"2014","unstructured":"Dom\u00ednguez RO, Pagano MA, Marschoff ER, Gonz\u00e1lez SE, Repettod M, Serra JA. Alzheimer disease and cognitive impairment associated withdiabetes mellitus type 2: associations and a hypothesis. Neurologia. 2014;29(9):567\u201372.","journal-title":"Neurologia"},{"key":"2199_CR73","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s001250051221","volume":"42","author":"HP Hammes","year":"1999","unstructured":"Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG, Brownlee M, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999;42:728\u201336.","journal-title":"Diabetologia"},{"key":"2199_CR74","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","volume":"93","author":"SY Goh","year":"2008","unstructured":"Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93:1143\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"2199_CR75","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","volume":"91","author":"MA Smith","year":"1994","unstructured":"Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U s a. 1994;91:5710\u20134.","journal-title":"U s a"},{"key":"2199_CR76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.taap.2006.01.003","volume":"212","author":"A Rolo","year":"2006","unstructured":"Rolo A, Palmeira C. Diabetes and mitocondrial function: roleof hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167\u201378.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2199_CR77","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","volume":"51","author":"DE Kelley","year":"2002","unstructured":"Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944\u201350.","journal-title":"Diabetes"},{"key":"2199_CR78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","volume":"84","author":"G Verdile","year":"2015","unstructured":"Verdile G, Fuller S, Martins RN. The role of type 2 diabetes in neurodegeneration. Neurobiol dis. 2015;84:22\u201338.","journal-title":"Neurobiol dis"},{"key":"2199_CR79","first-page":"1","volume":"65","author":"XJ Han","year":"2011","unstructured":"Han XJ, Tomizawa K, Fujimura A, Ohmori I, Nishiki T, Matsushita M, et al. Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta med Okayama. 2011;65:1\u201310.","journal-title":"Acta med Okayama"},{"key":"2199_CR80","unstructured":"DiTacchio K. The effect of AMPK activation on Alzheimer's-like symptoms in APP mice. UC San Diego Electronic Theses and Dissertations 2011; http:\/\/escholarship.org\/uc\/item\/0rh8k3sg [access 2017.04.10]."},{"key":"2199_CR81","doi-asserted-by":"crossref","first-page":"e","DOI":"10.1371\/journal.pone.0102420","volume":"9","author":"MM Hettich","year":"2014","unstructured":"Hettich MM, Mattes F, Ryan DP, Griesche N, Schroder S, Dorn S, et al. The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex. Plos one. 2014;9:e\u2013102420.","journal-title":"Plos one"},{"key":"2199_CR82","first-page":"564","volume":"101","author":"J Li","year":"2012","unstructured":"Li J, Deng J. Sheng., Zuo Z. Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol. Biochem. Beh. 2012;101:564\u201374.","journal-title":"Beh"},{"key":"2199_CR83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainresbull.2016.02.009","volume":"121","author":"C Zhou","year":"2016","unstructured":"Zhou C, Sun R, Zhuang S, Sun C, Jiang Y, Cui Y, et al. Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity. Brain res Bul. 2016;121:241\u20135.","journal-title":"Brain res Bul"},{"key":"2199_CR84","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.cub.2016.07.017","volume":"26","author":"T Niccoli","year":"2016","unstructured":"Niccoli T, Cabecinha M, Tillmann A, Kerr F, Wong CT, Cardenes D, et al. Increased glucose transport into neurons rescues A\u00df toxicity in drosophila. Curr Biol. 2016;26:2291\u2013300.","journal-title":"Curr Biol"},{"issue":"2","key":"2199_CR85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008996","volume":"5","author":"WB Potter","year":"2010","unstructured":"Potter WB, O'Riordan KJ, Barnett D, Osting SM, Wagoner M, Burger C, et al. Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One. 2010;5(2):e8996.","journal-title":"PLoS One"},{"key":"2199_CR86","first-page":"1046","volume":"2015","author":"P Picone","year":"1853","unstructured":"Picone P, Nuzzo D, Caruana L, Messina E, Barea A, Vasto S, et al. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-\u039aB activation: use of insulin to attenuate metformin's effects. Bioch Biophys Acta. 1853;2015:1046\u201359.","journal-title":"Bioch Biophys Acta"},{"key":"2199_CR87","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.18632\/aging.101004","volume":"8","author":"P Picone","year":"2016","unstructured":"Picone P, Vilasi S, Librizzi F, Contardi M, Nuzzo D, Caruana L, et al. Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates. Aging. 2016;8:1718\u201320.","journal-title":"Aging"},{"key":"2199_CR88","unstructured":"Acetylcholinesterase: A gorge-ous enzyme: Protein Data Bank in Europe; http:\/\/www.ebi.ac.uk\/pdbe\/quips?story=AChE [access 1.04.2017]."},{"key":"2199_CR89","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0959-440X(92)90207-N","volume":"2","author":"JL Sussman","year":"1992","unstructured":"Sussman JL, Silman I. Acetylcholinesterase: structure and use as a model for specific cation-protein interactions. Curr Opinion Struct Biol. 1992;2:721\u20139.","journal-title":"Curr Opinion Struct Biol"},{"key":"2199_CR90","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.3390\/molecules170910142","volume":"17","author":"A Imramovsky","year":"2012","unstructured":"Imramovsky A, Stepankova S, Vanco J, Pauk K, Monreal-Ferriz J, Vinsova J, et al. Acetylcholinesterase-inhibiting activity of Salicylanilide N-Alkylcarbamates and their molecular docking. Molecules. 2012;17:10142\u201358.","journal-title":"Molecules"},{"key":"2199_CR91","first-page":"1","volume":"4","author":"MS Gracia-Ayllon","year":"2011","unstructured":"Gracia-Ayllon MS, Small DH, Avila J, Saez-Valero J. Revisiting the role of acetylcholinesterase in Alzheimer\u2019s disease: cross-talk with P-tau and \u03b2-amyloid. Front Mol Neurosc. 2011;4:1\u20139.","journal-title":"Front Mol Neurosc"},{"key":"2199_CR92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0304-3940(92)90805-H","volume":"14","author":"T Arendt","year":"1992","unstructured":"Arendt T, Bruckner MK. Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's disease. Neurosci Lett. 1992;14:63\u20136.","journal-title":"Neurosci Lett"},{"key":"2199_CR93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2011.01.022","volume":"220","author":"P Bhutada","year":"2011","unstructured":"Bhutada P, Mundhada Y, Bansod K, Tawaria S, Patil S, Dixit P, et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Beh Brain res. 2011;220:30\u201341.","journal-title":"Beh Brain res"},{"key":"2199_CR94","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.biopha.2016.10.043","volume":"84","author":"JA Saliua","year":"2016","unstructured":"Saliua JA, Oboh G, Omojokun OS, Rochad J, Schetinger MR, Guterries J, et al. Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet\/streptozotocin induced diabetes in rats\u2019 brain and platelets. Biomed Pharmacother. 2016;84:1194\u2013201.","journal-title":"Biomed Pharmacother"},{"key":"2199_CR95","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2016.08.016","volume":"258","author":"NMS Arafa","year":"2016","unstructured":"Arafa NMS, Marie MA, AlAzimi SA. Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model. Chemico-Biol Interact. 2016;258:79\u201388.","journal-title":"Chemico-Biol Interact"},{"key":"2199_CR96","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00213-016-4301-2","volume":"233","author":"DK Mostafa","year":"2016","unstructured":"Mostafa DK, Ismail CA, Ghareeb DA. Differential metformin dose-dependent effects on cognition in rats: role of Akt. Psychopharmacol. 2016;233:2513\u201324.","journal-title":"Psychopharmacol"},{"key":"2199_CR97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-511X-4-18","volume":"4","author":"GR Sridhar","year":"2005","unstructured":"Sridhar GR, Nirmala G, Apparao A, Madhavi AS, Sreelatha S, Rani JS. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids Health dis. 2005;4:18.","journal-title":"Lipids Health dis"},{"key":"2199_CR98","first-page":"7","volume":"85","author":"CA Abott","year":"1993","unstructured":"Abott CA, Mackness MI, Kumar S, Olukoga AO, Gordon C, Arrol S. Relationship between serum butyrylcholinesterase activity, hypertriglyceridemia and insulin sensitivity in diabetes mellitus. Clin Sci. 1993;85:7\u201381.","journal-title":"Clin Sci"},{"key":"2199_CR99","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","volume":"102","author":"NH Greig","year":"2005","unstructured":"Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scall C. Selective butyrylcholinesterase inhibition elevated brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci. 2005;102:17213\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2199_CR100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(94)91852-X","volume":"640","author":"P Gomez-Rooms","year":"1994","unstructured":"Gomez-Rooms P, Bourse C. Ultrastructural localization of butyrylcholinesterase on neurofibrillay degeneration sites in the brains of aged and Alzheimer's disease patients. Brain res. 1994;640:17\u201334.","journal-title":"Brain res"},{"key":"2199_CR101","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2004.08.057","volume":"371","author":"AV Raygani","year":"2004","unstructured":"Raygani AV, Zahrai M, Soltanzadeh A, Doosti M, Javadi E, Pourmotabbed T. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer\u2019s disease. Neurosci Lett. 2004;371:142\u20136.","journal-title":"Neurosci Lett"},{"key":"2199_CR102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2005.11.002","volume":"22","author":"DA Butterfield","year":"2006","unstructured":"Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol dis. 2006;22:223\u201332.","journal-title":"Neurobiol dis"},{"key":"2199_CR103","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:759\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2199_CR104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21\u201343.","journal-title":"Prog Neurobiol"},{"key":"2199_CR105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijdevneu.2004.07.006","volume":"22","author":"J Apelt","year":"2004","unstructured":"Apelt J, Bigl M, Wunderlich P, Schliebs R. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J dev Neurosci. 2004;22:475\u201384.","journal-title":"Int J dev Neurosci"},{"issue":"Suppl. 2","key":"2199_CR106","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3233\/JAD-2010-100504","volume":"20","author":"PH Reddy","year":"2010","unstructured":"Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U. Amyloid-beta and mitochondria in aging and Alzheimer\u2019s disease: implications for synaptic damage and cognitive decline. J Alzheimers dis. 2010;20(Suppl. 2):499\u2013512.","journal-title":"J Alzheimers dis"},{"key":"2199_CR107","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","volume":"27","author":"R Sultana","year":"2006","unstructured":"Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, et al. Oxidative modification and down-regulation of Pin1 in Alzheimer\u2019s disease hippocampus: a redox proteomics analysis. Neurobiol Aging. 2006;27:918\u201325.","journal-title":"Neurobiol Aging"},{"key":"2199_CR108","first-page":"729","volume":"2012","author":"V Calabrese","year":"1822","unstructured":"Calabrese V, Cornelius C, Leso V, Trovato-Salinaro A, Ventimiglia B, Cavallaro M, et al. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta. 1822;2012:729\u201336.","journal-title":"Biochim Biophys Acta"},{"key":"2199_CR109","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nbd.2008.02.013","volume":"30","author":"JW Russell","year":"2008","unstructured":"Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol dis. 2008;30:420\u20139.","journal-title":"Neurobiol dis"},{"key":"2199_CR110","first-page":"1693","volume":"2014","author":"DA Butterfield","year":"1842","unstructured":"Butterfield DA, Di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta. 1842;2014:1693\u2013706.","journal-title":"Biochim Biophys Acta"},{"key":"2199_CR111","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama. 2001;286:327\u201334.","journal-title":"Jama"},{"key":"2199_CR112","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","volume":"28","author":"A Parachikova","year":"2007","unstructured":"Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, et al. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging. 2007;28:1821\u201333.","journal-title":"Neurobiol Aging"},{"key":"2199_CR113","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0924-977X(02)00107-4","volume":"12","author":"A Cagnin","year":"2002","unstructured":"Cagnin A, Gerhard A, Banati RB. In vivo imaging of neuroinflammation. Eur Neuropsychopharmacol. 2002;12:581\u20136.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2199_CR114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/gerona\/54.7.M357","volume":"54","author":"H Bruunsgaard","year":"1999","unstructured":"Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol a Biol Sci med Sci. 1999;54:357\u201364.","journal-title":"J Gerontol a Biol Sci med Sci"},{"issue":"18","key":"2199_CR115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2014.04.130","volume":"4","author":"RR Zhao","year":"2014","unstructured":"Zhao RR, Xu XC, Xu F, Zhang WL, Zhang WL, Liu LM, et al. Metformin protects against seizues, learning and memory impairments and oxidative damage inducet by pentylenetetrazole-induced kindling in mice. Biochem Biophys Redearch Comm. 2014;4(18):414\u20137.","journal-title":"Biochem Biophys Redearch Comm"},{"key":"2199_CR116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2016.05.013","volume":"1644","author":"WH Oliveira","year":"2016","unstructured":"Oliveira WH, Nunes AK, RochaFran\u00e7a ME, Santos LA, Bezerra L\u00f3s D, Rocha SW, et al. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain res. 2016;1644:149\u201360.","journal-title":"Brain res"},{"key":"2199_CR117","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbi.2014.03.013","volume":"216","author":"J Dai","year":"2014","unstructured":"Dai J, Liu M, Ai Q, Lin L, Wud K, Deng X, et al. Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury. Chemico-Biol. Interact. 2014;216:34\u201342.","journal-title":"Chemico-Biol. Interact."},{"key":"2199_CR118","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejphar.2015.06.010","volume":"764","author":"J Ma","year":"2015","unstructured":"Ma J, Yu H, Liu J, Chen Y, Wang Q, Xiang L. Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur. J. Pharm. 2015;764:599\u2013606.","journal-title":"Eur. J. Pharm."},{"key":"2199_CR119","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.lfs.2016.02.024","volume":"148","author":"B Khallaghi","year":"2016","unstructured":"Khallaghi B, Safarian F, Nasoohi S, Ahmadiani A, Dargahi L. Metformin-induced protection against oxidative stress is associatedwith AKT\/mTOR restoration in PC12 cells. Life Scie. 2016;148:286\u201392.","journal-title":"Life Scie"},{"key":"2199_CR120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/meta.2003.50093","volume":"52","author":"D Bonnefont-Rousselot","year":"2003","unstructured":"Bonnefont-Rousselot D, Raji B, Walrand S, Gardes-Albert M, Jore D, Legrand A. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism. 2003;52:586\u20139.","journal-title":"Metabolism"},{"key":"2199_CR121","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.metabol.2005.01.029","volume":"54","author":"N Ouslimani","year":"2005","unstructured":"Ouslimani N, Peynet J, Bonnefont-Rousselot D, Therond P, Legrand A, Beaudeux JL. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism. 2005;54:829\u201334.","journal-title":"Metabolism"},{"key":"2199_CR122","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2013.10.025","volume":"232","author":"B Batchuluun","year":"2014","unstructured":"Batchuluun B, Inoguchi T, Sonoda N, Sasaki S, Inoue T, Fujimura Y, et al. Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis. 2014;232:156\u201364.","journal-title":"Atherosclerosis"},{"key":"2199_CR123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdiacomp.2016.09.001","volume":"31","author":"J Sung Moon","year":"2017","unstructured":"Sung Moon J, Karunakaran U, Elumalai S, Lee IK, Woo Lee H, Kim YW, et al. Metformin prevents glucotoxicity by alleviating oxidative and ER stress\u2013induced CD36 expression in pancreatic beta cells. J Diab Complic. 2017;31:21\u201330.","journal-title":"J Diab Complic"},{"key":"2199_CR124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","volume":"32","author":"A Esteghamati","year":"2013","unstructured":"Esteghamati A, Eskandari D, Mirmiranpour H, Noshad S, Mousavizadeh M, Hedayati M, et al. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr. 2013;32:179\u201385.","journal-title":"Clin Nutr"},{"key":"2199_CR125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2013.05.006","volume":"27","author":"H Mirmiranpour","year":"2013","unstructured":"Mirmiranpour H, Mousavizadeh M, Noshad S, Ghavami M, Ebadi M, Ghasemiesfe M, et al. Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial. J. Diab. Complic. 2013;27:501\u20137.","journal-title":"J. Diab. Complic."},{"key":"2199_CR126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2010.11.030","volume":"93","author":"A Chakraborty","year":"2011","unstructured":"Chakraborty A, Chowdhury S, Bhattacharyy M. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes res Clin Pract. 2011;93:56\u201362.","journal-title":"Diabetes res Clin Pract"},{"key":"2199_CR127","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pharep.2013.11.008","volume":"66","author":"\u0141 Bu\u0142dak","year":"2014","unstructured":"Bu\u0142dak \u0141, \u0141abuzek K, Bu\u0142dak RJ, Koz\u0142owski M, Machnik G, Liber S, et al. Metformin affects macrophages\u2019 phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes\/macrophages. Pharm rep. 2014;66:418\u201329.","journal-title":"Pharm rep"},{"key":"2199_CR128","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K Labuzek","year":"2010","unstructured":"Labuzek K, Suchy D, Garbiel B, Bielecka A, Liber S, Okopie\u0144 B. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharm. Rep. 2010;62:956\u201365.","journal-title":"Pharm. Rep."},{"key":"2199_CR129","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1021\/jm900274q","volume":"52","author":"KM Huttunen","year":"2009","unstructured":"Huttunen KM, Mannila A, Laine K, Kemppainen E, Lepp\u00e4nen J, Veps\u00e4l\u00e4inen J, et al. The first Bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. J med Chem. 2009;52:4142\u20138.","journal-title":"J med Chem"},{"key":"2199_CR130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ejps.2013.05.023","volume":"49","author":"KM Huttunen","year":"2013","unstructured":"Huttunen KM, Lepp\u00e4nen J, Laine K, Veps\u00e4l\u00e4inen J, Rautio J. Convenient microwave-assisted synthesis of lipophilic sulfonamide prodrugs of metformin. Eur J Pharm Scie. 2013;49:624\u20138.","journal-title":"Eur J Pharm Scie"},{"issue":"2","key":"2199_CR131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bmcl.2015.12.003","volume":"26","author":"J Rautio","year":"2016","unstructured":"Rautio J, Vernerov\u00e1 M, Aufderhaar I, Huttunen KM. Glutathione-S-transferase selective release of metformin from its sulfonamide prodrug. Bioorg med Chem Lett. 2016;26(2):355\u201360.","journal-title":"Bioorg med Chem Lett"},{"key":"2199_CR132","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.exger.2012.07.014","volume":"47","author":"LG Exalto","year":"2012","unstructured":"Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Geront. 2012;47:858\u201364.","journal-title":"Exp Geront"},{"key":"2199_CR133","first-page":"S0925","volume":"16","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla R, Thirumala V, Reddy PH. Is Alzheimer's disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta. 2016;16:S0925\u20134439.","journal-title":"Biochim Biophys Acta"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-017-2199-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2199-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:06:13Z","timestamp":1719230773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-017-2199-y"}},"subtitle":["Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla"],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":133,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1007\/s11095-017-2199-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]},"assertion":[{"value":"4 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}